Cooper PE Ratio 2006-2018 | COO

Current and historical PE ratio for Cooper (COO) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Cooper (COO) as of April 30, 2018 is 22.59.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.027B $2.139B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $66.026B 24.73
Align Technology (ALGN) United States $29.131B 86.13
McKesson (MCK) United States $27.561B 10.81
AmerisourceBergen (ABC) United States $19.323B 14.07
Laboratory Of America Holdings (LH) United States $19.077B 18.43
Cardinal Health (CAH) United States $15.783B 9.96
Henry Schein (HSIC) United States $11.530B 20.43
DENTSPLY SIRONA (XRAY) United States $10.314B 17.31
West Pharmaceutical Services (WST) United States $7.360B 41.00
Merit Medical Systems (MMSI) United States $2.811B 42.23
Halyard Health (AVNS) United States $2.765B 22.62
Patterson (PDCO) United States $2.171B 13.64
CONMED (CNMD) United States $2.069B 35.99
STAAR Surgical (STAA) United States $1.351B 463.57
Atrion (ATRI) United States $1.143B 32.63
Invacare (IVC) United States $0.684B 0.00
Endologix (ELGX) United States $0.462B 0.00
Antares Pharma (ATRS) United States $0.422B 0.00
Lifevantage (LFVN) United States $0.133B 27.47
Aceto (ACET) United States $0.105B 4.28
Pro-Dex (PDEX) United States $0.029B 12.77
Milestone Scientific (MLSS) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.027B 0.00
Biolase (BIOL) United States $0.027B 0.00